COHN - FRO ACHR and KC are among pre market gainers
2023-06-13 08:32:16 ET
- First Wave BioPharma ( FWBI ) +103% Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis.
- Millennium Group International ( MGIH ) +48% .
- YS Biopharma ( YS ) +37% .
- Cohen & Company ( COHN ) +29% .
- Manchester United ( MANU ) +15% shares surge 25% on local report Qatar bid will succeed.
- Motorcar Parts of America ( MPAA ) +10% Record Sales for Fiscal 2023 Fourth Quarter and Year.
- Silo Pharma ( SILO ) +19% Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic.
- Eastside Distilling ( EAST ) +10% .
- SunCar Technology Group ( SDA ) +10% .
- Kingsoft Cloud Holdings ( KC ) +8% .
- VistaGen Therapeutics ( VTGN ) +5% Announces European Patent Office Intention to Grant New PH80 Nasal Spray Patent for the Treatment of Migraine.
- Casa Systems ( CASA ) +7% .
- Archer Aviation ( ACHR ) +7% .
- X4 Pharmaceuticals ( XFOR ) +6% Expected to Join Russell 3000 Index.
- Oracle Corporation ( ORCL ) +6% stock jumps after Goldman upgrades following 'solid' Q4 results.
- Frontline ( FRO ) +5% .
- Compugen ( CGEN ) +5% regains compliance with Nasdaq listing standards.
- Acumen Pharmaceuticals ( ABOS ) +5% to Present Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease During Featured Research Session at the Alzheimer’s Association International Conference 2023.
For further details see:
FRO, ACHR and KC are among pre market gainers